Analysts: Halozyme Therapeutics Inc (HALO.A)

HALO.A on American Stock Exchange

9.60USD
12:34pm EDT
Price Change (% chg)

$0.25 (+2.70%)
Prev Close
$9.35
Open
$9.38
Day's High
$9.60
Day's Low
$9.38
Volume
1,400
Avg. Vol
7,404
52-wk High
$18.16
52-wk Low
$6.90

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.13 December 30 Oct 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 7 18.84 24.20 14.30 26.30
Quarter Ending Mar-15 3 24.27 27.60 17.80 31.18
Year Ending Dec-14 8 65.90 74.20 58.60 65.83
Year Ending Dec-15 8 103.09 145.30 74.60 126.71
Earnings (per share)
Quarter Ending Dec-14 8 -0.13 -0.04 -0.19 -0.08
Quarter Ending Mar-15 3 -0.12 -0.08 -0.17 -0.02
Year Ending Dec-14 9 -0.61 -0.44 -0.74 -0.45
Year Ending Dec-15 9 -0.29 0.13 -0.58 -0.10

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 13.71 18.39 4.68 34.10
Quarter Ending Mar-14 13.37 11.97 1.41 10.51
Quarter Ending Dec-13 16.39 12.50 3.89 23.75
Quarter Ending Sep-13 14.62 16.01 1.39 9.54
Quarter Ending Jun-13 11.29 14.45 3.17 28.07
Earnings (per share)
Quarter Ending Jun-14 -0.14 -0.13 0.01 -8.00
Quarter Ending Mar-14 -0.14 -0.22 0.08 -62.12
Quarter Ending Dec-13 -0.17 -0.19 0.02 -10.85
Quarter Ending Sep-13 -0.15 -0.17 0.02 -15.25
Quarter Ending Jun-13 -0.13 -0.20 0.07 -49.48

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 18.84 18.84 18.85 19.06 26.30
Quarter Ending Mar-15 24.27 24.27 24.32 24.82 31.18
Year Ending Dec-14 65.90 65.90 65.92 66.94 65.83
Year Ending Dec-15 103.09 103.09 103.11 103.71 126.71
Earnings (per share)
Quarter Ending Dec-14 -0.13 -0.13 -0.13 -0.13 -0.08
Quarter Ending Mar-15 -0.12 -0.12 -0.12 -0.12 -0.02
Year Ending Dec-14 -0.61 -0.61 -0.61 -0.62 -0.45
Year Ending Dec-15 -0.29 -0.29 -0.29 -0.29 -0.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 0 1
Quarter Ending Mar-15 0 0 0 1
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 1
Earnings
Quarter Ending Dec-14 0 0 0 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks